VR Logo

Pharma Funds Gain

While debt funds ended the week flat, pharma funds' category, which had delivered negative returns last week, topped the return chart this time to gain 0.74 per cent

Equity Funds
Technology funds failed to maintain their last week's edge in the week ended October 21. The category shed 2.69 per cent against the negative 3.15 per cent loss of benchmark BSE IT Index to become the worst equity funds' category.

Pharma funds' category, which had delivered negative returns last week, topped the return chart this week. The category gained 0.74 per cent against the 0.31 per cent gain of the benchmark BSE Healthcare Index. Diversified and tax-planning funds' categories ended the week down 0.59 and 0.44 per cent, while the BSE Sensex shed 1.26 per cent in the week ended October 21. FMCG funds too lost 0.59 per cent against the negative 2.36 per cent return of BSE FMCG Index. Petroleum funds, which were down 0.94 per cent last week, delivered a positive return of 0.53 per cent this time.

Interestingly, even as all the equity funds' categories beat their benchmarks, only pharma and petro funds could manage positive returns.

Hybrid equity oriented funds too shed 0.45 per cent, though not as much as previous week loss of 1.46 per cent.

Debt Fund
Most of the debt funds' categories ended the week flat. Debt: short-term (0.07 per cent), gilt: short-term (0.09 per cent), debt: ultra short-term (0.08 per cent), floaters (0.09 per cent), gilt: medium and long-term (0.38 per cent) and debt: medium-term (0.20 per cent) delivered positive returns, while MIPs lost 0.01 per cent.